Regardless, the identification of novel interacting partners of PAK1 that are specifically involved in the insulin-stimulated glucose uptake process, and not in the survival pathway, will provide us with a tantalizing opportunity to identify potential therapeutic targets for T2D without affecting the normal survival/anti-apoptotic pathways. The gene discussed is INS; the disease is type 2 diabetes mellitus.